The tariff classification of Hydroxychloroquine Sulfate Tablets in dosage form, from India
Reasoning
The tariff classification of Hydroxychloroquine Sulfate Tablets in dosage form, from India
Cite this ruling
CBP Ruling N307483 (3004909210): The tariff classification of Hydroxychloroquine Sulfate Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of RIBASPHERE™ (ribavirin) capsules
The tariff classification of cough suppressant lozenges from England.
The tariff classification of dietary supplements from Italy
The tariff classification of IQUIX® (levofloxacin ophthalmic solution) 1.5%, imported in bulk and measured-dose forms, from Finland
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use